Gilead presents new data from HIV cure research program and collaborations exploring novel investigational combinations and strategies
– Innovative investigational approaches include targeting of the HIV viral reservoir and enhancing immune response in the absence of antiretroviral therapy –
– Findings support continued evaluation of novel strategies including broadly neutralizing HIV antibodies, vaccine candidates, and TLR agonists –
Read the full press release here.
Source : Gilead Sciences, Inc.
Related HIV and Co-Infections News
-
[CROI 2026] TheBodyPro: HIV cure research advances by important steps (but no leaps)
-
Medical Xpress: Norway’s ‘Oslo patient’ reaches HIV remission after rare stem cell transplant donated by brother
-
UNC School of Medicine: Researchers demonstrate drug’s effectiveness in drawing out dormant HIV from immune cells
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.